Searchable abstracts of presentations at key conferences in endocrinology

ea0090ep247 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

Intake of alpha-lipoic acid (thioctic acid) and insulin autoinmune syndrome. A case report

Urzaiz Leticia Serrano , Trincado Pablo , Diego Patricia De , Gonzalez Wendy Valeria , Lacarta Macarena , Moreno Carlos

A 52-year-old female patient with no previous history of interest, and with no prescribed habitual chronic treatment, was admitted to our hospital to be studied for symptomatic hypoglycemias of one month of evolution. Symptoms consisted of malaise, hunger, tremors and profuse sweating that disappeared with food ingestion. She referred hypoglycemic (up to 40 mg/dl) episodes daily, both in fasting and postprandial periods. She even suffered nocturnal episodes that woke her up. O...

ea0032p356 | Diabetes | ECE2013

Risk factors for impaired glucose tolerance and diabetes mellitus after liver transplantation

Martinez Guillermo , Allo Gonzalo , Fernandez Ana , Aramendi Mercedes , Jimenez Carlos , Moreno Enrique , Hawkins Federico

Risk factors involved in new-onset diabetes mellitus after transplantation (NODAT) remain unclear. Clinical studies have demonstrated the association between low vitamin D levels with insulin resistance and diabetes. In animal models, osteocalcin deficiency leads to high glucose levels and insulin resistance.The aim of this study is to evaluate the prevalence of NODAT and other alterations of glucose metabolism after liver transplantation (LT) at our ins...

ea0081p365 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Flash glucose monitoring in patients with DM3c

Rebollo-Roman Angel , Leon-Idougourram Soraya , Manuel Alzas Teomiro Carlos , Moreno-Moreno Paloma , Angeles Galvez Moreno Maria

Objective: Flash glucose monitoring (FGM) allows non-invasive glucose level assessment. Since November 2020 the use of this system is subsidized in patients with type 3c diabetes (DM3c) Our objective was to describe the characteristics of these patients and their glycemic control expressed as times in range.Methods and patients: Observational longitudinal clinical study between January 2021 and December 2021 in patients with DM3c in which FGM implementat...

ea0090ep1130 | Late Breaking | ECE2023

Flash glucose monitoring in patients with DM3c

Rebollo-Roman Angel , Carmen Serrano Laguna Mª , Manuel Alzas Teomiro Carlos , Moreno-Moreno Paloma , Angeles Galvez Moreno Maria

Objective: Flash glucose monitoring (FGM) facilitates non-invasive glucose level assessment. Since November 2020 this system is subsidized in patients with type 3c diabetes (DM3c) Our objective was to describe the characteristics of these patients and their glycemic control expressed as times in range.Methods and patients: Observational longitudinal clinical study between January 2021 and January 2023 in patients with DM3c.Results:...

ea0063oc9.1 | Thyroid 2 | ECE2019

3D mapping and in silico predictions of the DEHAL1 enzyme as a tool to discriminate pathogenic mutations from non-functional variants in hypothyroidism

Jorge Garcia-Gimenez , Angel Gonzalez Wong , Cristian Gonzalez-Guerrero , Ainhoa Iglesias , Emily Styrers , Jose Cocho , Leonardo Pardo , Carlos Moreno J

Next Generation Sequencing (NGS) is becoming widely used for genetic diagnosis. While its capacity for detection of human genetic variations (GV) is outstanding, drawbacks is the identification of numerous GV of which functional significance cannot be predicted in silico by computer programs (variants of uncertain significance, VUS). Currently, only sensitive (but also expensive and time-demanding) in vitro cell assays, can trustfully ascertain pathogenicity ...

ea0056p778 | Pituitary - Basic | ECE2018

Comparative differential effects of secretagogues upon regulation of pituitary GH in several vertebrates

Sosa Valeria Alejandra Urban , Mendoza Jose Avila , Salas Martha Carranza , Moreno Carlos Guillermo Martinez , Munoz Maricela Luna , Aramburo Carlos

It is known that the synthesis and release of pituitary GH is controlled by complex neuroendocrine mechanisms that involve several neuropeptides, such as GHRH, SST, PACAP, TRH, GnRH, Ghrelin, among other regulators. Previous reports indicate that, during vertebrate evolution, the potency and efficacy of these secretagogues may vary and play differential effects upon GH regulation. In this work we aimed to study, in vitro, the capacity of these peptides to control the ...